Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsTrendsHealth

Delhi to get 5.5 lakh COVID-19 vaccine doses for 18-44 age group in June, says Manish Sisodia

Manish Sisodia also alleged "mismanagement" by the central government and sought to know how private hospitals were getting vaccines while states were being told that there are no stocks.

May 29, 2021 / 03:10 PM IST

Delhi will receive 5.5 lakh COVID-19 jabs for the 18-44 age group from the Centre next month, but not before June 10, Deputy Chief Minister Manish Sisodia said on Saturday, as he accused the central government of "sitting on" the vaccine distribution system.

Sisodia also alleged "mismanagement" by the central government and sought to know how private hospitals were getting vaccines while states were being told that there are no stocks.

As against a requirement of 1.84 crore doses to vaccinate 92 lakh people in the 18-44 age group in Delhi, Centre provided 4.5 lakh doses in April and 3.67 lakh doses in May, he said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

"The Centre has informed us that a limited stock of 5.5 lakh doses will be provided in June, but not before June 10," Sisodia said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Claiming that inoculation centres for the 18-44 age group are shutting down due to lack of vaccines, he said the Centre should share the data on doses provided to the states and the private sector.

The deputy CM added that he had raised the demand of zero GST on COVID-19 vaccines, oxygen cylinders, concentrators, ventilators and other equipment used in the treatment of the viral disease during Friday's GST Council meeting.

The proposal fell through because of opposition from finance ministers of BJP-ruled states, Sisodia claimed.

Follow our full coverage of the coronavirus pandemic here.

Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

first published: May 29, 2021 03:10 pm
ISO 27001 - BSI Assurance Mark